There are no Focus articles on BRTX.
There are no Related articles on BRTX.
There are no Transcripts on BRTX.
Thu, May. 22, 9:00 AM
- With the intent of jointly studying the identities and metabolic functions of human brown adipose tissue and cell lines, BioRestorative Therapies (BRTX) and Pfizer (PFE) sign a two-year collaborative research agreement. The results of the research may be used by both companies.
- The ultimate objective is to determine if BioRestorative's cell lines have potential as a treatment for obesity.
Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.
BRTX vs. ETF Alternatives
BioRestorative Therapies, Inc. (www.biorestorative.com) develops products and medical procedures using cell and tissue protocols, primarily involving adult stem cells, including: brtxDISC(TM) (Disc Implanted Stem Cells) is an investigational non-surgical treatment for bulging and herniated... More
Other News & PR